169 related articles for article (PubMed ID: 24872478)
1. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
Quintyne KI; Neenan T; Casserly L; Gupta R
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872478
[TBL] [Abstract][Full Text] [Related]
2. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.
Costero O; Picazo ML; Zamora P; Romero S; Martinez-Ara J; Selgas R
Nephrol Dial Transplant; 2010 Mar; 25(3):1001-3. PubMed ID: 20019017
[TBL] [Abstract][Full Text] [Related]
4. Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.
Wong MK; Jarkowski A
Pharmacotherapy; 2009 Apr; 29(4):473-8. PubMed ID: 19323623
[TBL] [Abstract][Full Text] [Related]
5. Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Huang J; Wang T; Huang Y
Med Oncol; 2013 Mar; 30(1):436. PubMed ID: 23283650
[No Abstract] [Full Text] [Related]
6. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
Edeline J; Laguerre B; Rolland Y; Patard JJ
Ann Oncol; 2010 Jan; 21(1):186-7. PubMed ID: 19875754
[No Abstract] [Full Text] [Related]
7. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
8. Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.
Pandey M; Ramasamy M; Shukla M
World J Surg Oncol; 2018 Feb; 16(1):23. PubMed ID: 29409504
[TBL] [Abstract][Full Text] [Related]
9. A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma.
Pilanc KN; Elbüken F; Ordu Ç; Köksal G; Tekelioğlu MH; Okutur K; Göksel S; Köksal Ü; Akçal T; Tecimer C
Am J Ther; 2016; 23(2):e583-7. PubMed ID: 24901901
[TBL] [Abstract][Full Text] [Related]
10. Co-occurring adverse events enable early prediction of progression-free survival in metastatic renal cell carcinoma patients treated with sunitinib: a hypothesis-generating study.
Kucharz J; Dumnicka P; Kuzniewski M; Kusnierz-Cabala B; Herman RM; Krzemieniecki K
Tumori; 2015; 101(5):555-9. PubMed ID: 26045121
[TBL] [Abstract][Full Text] [Related]
11. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.
Molina AM; Feldman DR; Ginsberg MS; Kroog G; Tickoo SK; Jia X; Georges M; Patil S; Baum MS; Reuter VE; Motzer RJ
Invest New Drugs; 2012 Feb; 30(1):335-40. PubMed ID: 20711632
[TBL] [Abstract][Full Text] [Related]
13. Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma.
Rolleman EJ; Weening J; Betjes MG
Nephrol Dial Transplant; 2009 Jun; 24(6):2002-3. PubMed ID: 19332867
[No Abstract] [Full Text] [Related]
14. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A; Ravaud A; Thezenas S; Colas S; Beauval JB; Bensalah K; Geoffrois L; Thiery-Vuillemin A; Cormier L; Lang H; Guy L; Gravis G; Rolland F; Linassier C; Lechevallier E; Beisland C; Aitchison M; Oudard S; Patard JJ; Theodore C; Chevreau C; Laguerre B; Hubert J; Gross-Goupil M; Bernhard JC; Albiges L; Timsit MO; Lebret T; Escudier B
N Engl J Med; 2018 Aug; 379(5):417-427. PubMed ID: 29860937
[TBL] [Abstract][Full Text] [Related]
15. Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.
Ballardini P; Margutti G; Aliberti C; Manfredini R
Clin Drug Investig; 2009; 29(7):487-490. PubMed ID: 19499966
[TBL] [Abstract][Full Text] [Related]
16. Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
Noize P; Grelaud A; Bay JO; Chevreau C; Gross-Goupil M; Culine S; Ferrière JM; Moulin F; Robinson P; Balestra A; Lamarque S; Bernard MA; Lassalle R; Rouyer M; Droz-Perroteau C; Moore N; Fourrier-Réglat A; Ravaud A
Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1561-1569. PubMed ID: 28573786
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction.
Takahashi D; Nagahama K; Tsuura Y; Tanaka H; Tamura T
Clin Exp Nephrol; 2012 Apr; 16(2):310-5. PubMed ID: 21964704
[TBL] [Abstract][Full Text] [Related]
18. Blue toe syndrome and sunitinib.
Postema PG; Regeer MV; van der Valk PR; Stroes ES; Richel DJ
Int J Clin Oncol; 2011 Oct; 16(5):574-6. PubMed ID: 21136131
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.
Adams VR; Leggas M
Clin Ther; 2007 Jul; 29(7):1338-53. PubMed ID: 17825686
[TBL] [Abstract][Full Text] [Related]
20. [A case of pneumatosis intestinalis associated with sunitinib treatment for renal cell carcinoma].
Choi YA; Sim EH; Lee KE; Ko SY; Seo MJ; Yang YJ; Park JC; Park SY
Korean J Gastroenterol; 2013 Jun; 61(6):347-50. PubMed ID: 23877217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
